Taipei, Taiwan

Chi-Yuan Chen

USPTO Granted Patents = 10 


Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Chi-Yuan Chen

Introduction

Chi-Yuan Chen is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology and medical devices, holding a total of 10 patents. His work focuses on developing innovative solutions that address critical health challenges.

Latest Patents

One of Chi-Yuan Chen's latest patents is the development of DNAzymes for silencing the expression of EGFR. This invention provides DNAzymes capable of silencing the expression of EGFR at an allele-specific level. These allele-specific DNAzymes target the EGFR T790M mutation, effectively knocking down the expression of EGFR T790M mRNA while preserving the integrity of EGFR wild-type mRNA. This innovation has the potential to overcome T790M-derived TKI resistance in lung cancer patients, minimizing unwanted side effects on normal cells. Another notable invention is the Trigger Grip, which features a unique design that includes a body with an upper jaw, a pivot section, and a sleeve section. This device is engineered to enhance grip and functionality in various applications.

Career Highlights

Throughout his career, Chi-Yuan Chen has worked with several companies, including Netimage Corporation. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking inventions in his field.

Collaborations

Chi-Yuan Chen has collaborated with notable professionals, including Cheng-Fa Hsieh and Chih-Shin Lan. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Chi-Yuan Chen's contributions to the fields of biotechnology and medical devices are noteworthy. His innovative patents, particularly in silencing EGFR expression and enhancing grip technology, demonstrate his commitment to advancing healthcare solutions. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…